89
Views
24
CrossRef citations to date
0
Altmetric
Research Article

X-Linked Mental Retardation (XLMR): From Clinical Conditions to Cloned Genes

, &
Pages 117-158 | Published online: 29 Sep 2008

REFERENCES

  • Chiurazzi P, Oostra BA. Genetics of mental retardation. Curr Opin Pediatr 2000; 12: 529–35.
  • Lehrke R. Theory of X-linkage of major intellectual traits. Am J Ment Defic 1972; 76: 611–9.
  • Turner G, Turner B. X-linked mental retardation. J Med Genet 1974; 11: 109–13.
  • Neri G, Chiurazzi P. X-linked mental retardation. Adv Genet 1999; 41: 55–94.
  • Lubs HA. The other side of the coin: a hypothesis concerning the importance of genes for high intelligence and evolution of the X chromosome. Am J Med Genet 1999; 85: 206–8.
  • Zechner U, Wilda M, Kehrer-Sawatzki H, et al. A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution? Trends Genet 2001; 17: 697–701.
  • Herbst DS, Miller JR. Nonspecific X-linked mental retardation II: the frequency in British Columbia. Am J Med Genet 1980; 7: 461–9.
  • Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet 1996; 64: 196–7.
  • Stevenson RE, Procopio-Allen AM, Schroer RJ, Collins JS. Genetic syndromes among individuals with mental retardation. Am J Med Genet 2003; 123A: 29–32.
  • Neri G, Gurrieri F, Gal A, Lubs HA. XLMR genes: update 1990. Am J Med Genet 1991; 38: 186–9.
  • Chiurazzi P, Hamel BCJ, Neri G. XLMR genes: update 2000. Eur J Hum Genet 2001; 9: 71–81.
  • Stevenson RE, Schwartz CE, Schroer RJ. X-linked mental retardation. Oxford: Oxford University Press, 2000.
  • Frints SGM, Froyen G, Marynen P, Fryns JP. X-linked mental retardation: vanishing boundaries between non-specific (MRX) and syndromic (MRXS) forms. Clin Genet 2002; 62: 423–32.
  • Hendrich B, Bickmore W. Human diseases with underlying defects in chromatin structure and modification. Hum Mol Genet 2001; 10: 2233–42.
  • Toniolo D, D’Adamo P. X-linked non-specific mental retardation. Curr Opin Genet Dev 2000; 10: 280–5.
  • Ramakers GJA. Rho proteins, mental retardation, and the cellular basis of cognition. Trends Neurosci 2002; 25: 191–9.
  • Weatherall DJ, Higgs DR, Bunch C, et al. Hemoglobin H disease and mental retardation: a new syndrome or a remarkable coincidence? N Engl J Med 1981; 305: 607–12.
  • Yntema HG, Poppelaars FA, Derksen E, et al. Expanding phenotype of XNP mutations: mild to moderate mental retardation. Am J Med Genet 2002; 110: 243–7.
  • Lossi AM, Millan JM, Villard L, et al. Mutation of the XNP/ATR-X gene in a family with severe mental retardation, spastic paraplegia and skewed pattern of X inactivation: demonstration that the mutation is involved in the inactivation bias. Am J Hum Genet 1999; 65: 558–62.
  • Gibbons RJ, Brueton L, Buckle VJ, et al. Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet 1995; 55: 288–99.
  • Gibbons RJ, Suthers GK, Wilkie AOM, et al. X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome: localization to Xq12-q21.31 by X inactivation and linkage analysis. Am J Hum Genet 1992; 51: 1136–49.
  • Gibbons RJ, Picketts DJ, Villard L, et al. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell 1995; 80: 837–45.
  • Gibbons RJ, Bachoo S, Picketts DJ, et al. Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat Genet 1997; 17: 146–8.
  • Juberg RC, Marsidi I. A new form of X-linked mental retardation with growth retardation, deafness, and microgenitalism. Am J Hum Genet 1980; 32: 714–22.
  • Villard L, Gecz J, Mattei JF, et al. XNP mutation in a large family with Juberg-Marsidi syndrome. Nat Genet 1996; 12: 359–60.
  • Carpenter NJ, Waziri M, Liston J, Patil SR. Studies on X-linked mental retardation: evidence for a gene in region Xq11-q22. Am J Hum Genet 1988; 43: A139.
  • Abidi F, Schwartz CE, Carpenter NJ, et al. Carpenter-Waziri syndrome results from a mutation in XNP. Am J Med Genet 1999; 85: 249–51.
  • Sutherland GR, Gedeon AK, Haan EA, et al. Linkage studies with the gene for an X-linked syndrome of mental retardation, microcephaly and spastic diplegia (MRX2). Am J Med Genet 1988; 30: 493–508.
  • Martinez F, Tomas M, Millan JM, et al. Genetic localization of mental retardation with spastic diplegia to the pericentromeric region of the X chromosome: X inactivation in female carriers. J Med Genet 1998; 35: 284–7.
  • Holmes LB, Gang DL. Brief clinical report: an X-linked mental retardation syndrome with craniofacial abnormalities, microcephaly and club foot. Am J Med Genet 1984; 17: 375–82.
  • Stevenson RE, Abidi F, Schwartz CE, et al. Holmes-Gang syndrome is allelic with XLMR-hypotonic face syndrome. Am J Med Genet 2000; 94: 383–5.
  • Smith RD, Fineman RM, Myers GG. Short stature, psychomotor retardation, and unusual facial appearance in two brothers. Am J Med Genet 1980; 7: 5–9.
  • Ades LC, Kerr B, Turner G, et al. Smith-Fineman-Myers syndrome in two brothers. Am J Med Genet 1991; 40: 467–70.
  • Guion-Almeida ML, Tabith A Jr, Kokitsu-Nakata NM, et al. Smith-Fineman-Myers syndrome in apparently monozygotic twins. Am J Med Genet 1998; 79: 205–8.
  • Villard L, Fontes M, Ades LC, et al. Identification of a mutation in the XNP/ATR-X gene in a family reported as Smith-Fineman-Myers syndrome. Am J Med Genet 2000; 91: 83–5.
  • Abidi FE, Chudley AE, Daniels S, et al. Chudley-Lowry syndrome results from absence of the XNP protein. Am J Hum Genet 2002; 71(Suppl.): A2033.
  • Guerrini R, Shanahan JL, Carrozzo R, et al. A nonsense mutation of the ATRX gene causing mild mental retardation and epilepsy. Ann Neurol 2000; 47: 117–21.
  • Rett A. On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 1966; 116: 723–6.
  • Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23: 185–8.
  • Wan M, Lee SS, Zhang X, et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 1999; 65: 1520–9.
  • Kozinetz CA, Skender ML, MacNaughton N, et al. Epidemiology of Rett syndrome: a population-based registry. Pediatrics 1993; 91: 445–50.
  • Shahbazian MD, Zoghbi H. Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet 2002; 71: 1259–72.
  • Kerr AM, Armstrong DD, Prescott RJ, et al. Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry 1997; 6: 71–4.
  • Guideri F, Acampa M, Hayek G, et al. Reduced heart rate variability in patients affected with Rett syndrome: a possible explanation for sudden death. Neuropediatrics 1999; 30: 146–8.
  • De Bona C, Zappella M, Hayek G, et al. Preserved speech variant is allelic of classic Rett syndrome. Eur J Hum Genet 2000; 8: 325–30.
  • Zappella M, Meloni I, Longo I, et al. Preserved speech variants of the Rett syndrome: molecular and clinical analysis. Am J Med Genet 2001; 104: 14–22.
  • Coleman M. Is classical Rett syndrome ever present in males? Brain Dev 1990; 12: 31–2.
  • Schwartzman JS, De Souza AM, Faiwichow G, et al. Rett phenotype in patient with XXY karyotype: case report. Arq Neuropsiquiatr 1998; 56: 824–8.
  • Clayton-Smith J, Watson P, Ramsden S, et al. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 2000; 356: 830–2.
  • Topcu M, Akyerli C, Sayi A, et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet 2002; 10: 77–81.
  • Ravn K, Nielsen JB, Uldall P, et al. No correlation between phenotype and genotype in boys with a truncating MECP2 mutation. J Med Genet 2003; 40: e5.
  • Cheadle JP, Gill H, Fleming N, et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 2000; 9: 1119–29.
  • Claes S, Devriendt K, D’Adamo P, et al. X-linked severe mental retardation and a progressive neurological disorder in a Belgian family: clinical and genetic studies. Clin Genet 1997; 52: 155–61.
  • Meloni I, Bruttini M, Longo I, et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 2000; 67: 982–5.
  • Lindsay S, Splitt M, Edney S, et al. PPM-X: a new X-linked mental retardation syndrome with psychosis, pyramidal signs, and macroorchidism maps to Xq28. Am J Hum Genet 1996; 58: 1120–6.
  • Klauck SM, Lindsay S, Beyer KS, et al. A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 2002; 70: 1034–7.
  • Winnepenninckx B, Errijgers V, Hayez-Delatte F, et al. Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: is there a need for routine screening? Hum Mutat 2002; 20: 249–52.
  • Couvert P, Bienvenu T, Aquaviva C, et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 2001; 10: 941–6.
  • Claes S, Devriendt K, Lagae L, et al. The X-linked infantile spasms syndrome (MIM 308350) maps to Xp11.4-Xpter in two pedigrees. Ann Neurol 1997; 42: 360–4.
  • Strømme P, Mangelsdorf ME, Shaw MA, et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 2002; 30: 441–5.
  • Kitamura K, Yanazawa M, Sugiyama N, et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 2002; 32: 359–69.
  • Dobyns C, et al. Mutations of ARX cause a wide range of phenotypes including X-linked mental retardation, West syndrome or cryptogenic infantile spasms, other epileptic encephalopathies, agenesis of corpus callosum, X-linked lyssencephaly with abnormal genitalia and hydranencephaly. Tenth Manchester Birth Defects Conference 2002.
  • Bienvenu T, Poirier K, Friocourt G, et al. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet 2002; 11: 981–91.
  • Kalscheuer VM, Tao J, Donnelly A, et al. Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. Am J Hum Genet 2003; 72: 1401–11.
  • Philip N, Chabrol B, Lossi AM, et al. Mutations in the oligophrenin-1 gene (OPHN1) cause X-linked congenital cerebellar hypoplasia. J Med Genet 2003; 40: 441–6.
  • Bergmann C, Zerres K, Senderek J, et al. Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement, and cerebellar hypoplasia. Brain 2003; 126: 1537–44.
  • Van der Flier A, Sonnenberg A. Structural and functional aspects of filamins. Biochim Biophys Acta 2001; 1538: 99–117.
  • Robertson SP, Twigg SRF, Sutherland-Smith AJ, et al. Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. Nat Genet 2003; 33: 487–91.
  • Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991; 65: 905–14.
  • Murray A, Webb J, Grimley S, et al. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 1998; 35: 637–40.
  • Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 2000; 97: 189–94.
  • Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001; 57: 127–30.
  • Hundscheid RD, Braat DD, Kiemeney LA, et al. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod 2001; 16: 457–62.
  • Hundscheid RDL, Smits APT, Thomas CMG, et al. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure. Am J Med Genet 2003; 117A: 6–9.
  • Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 2003; 72: 869–78.
  • Leehey MA, Munhoz RP, Lang AE, et al. The fragile X premutation presenting as essential tremor. Arch Neurol 2003; 60: 117–21.
  • Macpherson J, Waghorn A, Hammans S, et al. Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum Genet 2003; 112: 619–20.8.
  • Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002; 125: 1760–71.
  • Willemsen R, Hoogeveen-Westerveld M, Reis S, et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet 2003; 12: 949–59.
  • Tassone F, Hagerman RJ, Taylor AK, et al. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000; 66: 6–15.
  • Kenneson A, Zhang F, Hagedorn CH, Warren ST. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and in premutation carriers. Hum Mol Genet 2001; 10: 1449–54.
  • Mankodi A, Logigian E, Callahan L, et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000; 289: 1769–73.
  • Piccini M, Vitelli F, Bruttini M, et al. FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation. Genomics 1998; 47: 350–8.
  • Meloni I, Vitelli F, Pucci L, et al. Alport syndrome and mental retardation: clinical and genetic dissection of the contiguous gene deletion syndrome in Xq22.3 (ATS-MR). J Med Genet 2002; 39: 359–65.
  • Meloni I, Muscettola M, Raynaud M, et al. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat Genet 2002; 30: 436–40.
  • Longo I, Frints SG, Fryns JP, et al. A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients. J Med Genet 2003; 40: 11–7.
  • Sandoval N, Bauer D, Brenner V, et al. The genomic organization of a human creatine transporter (CRTR) gene located in Xq28. Genomics 1996; 35: 383–5.
  • Iyer GS, Krahe R, Goodwin LA, et al. Identification of a testis-expressed creatine transporter gene at 16p11.2 and confirmation of the X-linked locus to Xq28. Genomics 1996; 34: 143–6.
  • Cecil KM, Salomons GS, Ball WS Jr, et al. Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 2001; 49: 401–4.
  • Salomons GS, van Dooren SJ, Verhoeven NM, et al. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 2001; 68: 1497–500.
  • Hahn KA, Salomons GS, Tackels-Horne D, et al. X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am J Hum Genet 2002; 70: 1349–56.
  • Bizzi A, Bugiani M, Salomons GS, et al. X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8. Ann Neurol 2002; 52: 227–31.
  • Item CB, Stockler-Ipsiroglu S, Stromberger C, et al. Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 2001; 69: 1127–33.
  • Stockler S, Isbrandt D, Hanefeld F, et al. Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet 1996; 58: 914–22.
  • Aldred MA, Dry KL, Knight-Jones EB, et al. Genetic analysis of a kindred with X-linked mental handicap and retinitis pigmentosa. Am J Hum Genet 1994; 55: 916–22.
  • Carpenter NJ, Givens H, Randell L, Lutz R, Miles JH. Clinical characterization and gene mapping of a family with X-linked mental retardation, facial dysmorphism, congenital hip dislocation and skewed pattern of X-inactivation. Am J Hum Genet 2000; 67(Suppl. 2): 315.
  • Chudley AE, Tackels DC, Lubs HA, et al. X-linked mental retardation syndrome with seizures, hypogammaglobulinemia, and progressive gait disturbance is regionally mapped between xq21.33 and Xq23. Am J Med Genet 1999; 85: 255–62.
  • Golabi M, Ito M, Hall BD. A new X-linked multiple congenital anomalies/mental retardation syndrome. Am J Med Genet 1984; 17: 367–74.
  • Hall BD, Robl JM. New X-linked MR/MCA syndrome associated with cleft lip/palate, up-slanted/short palpebral fissures, high nasal bridge, prominent nasal tip, inguinal hernia, and minor digital defects. Am J Hum Genet 1999; 65: A151.
  • Hamel BC, Mariman EC, van Beersum SE, Schoonbrood-Lenssen AM, Ropers HH. Mental retardation, congenital heart defect, cleft palate, short stature, and facial anomalies: a new X-linked multiple congenital anomalies/mental retardation syndrome: clinical description and molecular studies. Am J Med Genet 1994; 51: 591–7.
  • Hockey A. X-linked intellectual handicap and precocious puberty with obesity in carrier females. Am J Med Genet 1986; 23: 127–37.
  • Homfray T, Holland T, Patton M. A new X-linked mental retardation syndrome. Clin Dysmorphol 1995; 4: 289–93.
  • Johnson JP, Nelson R, Schwartz CE. A family with mental retardation, variable macrocephaly and macro-orchidism, and linkage to Xq12-q21. J Med Genet 1998; 35: 1026–30.
  • Martin DM, Probst FJ, Camper SA, Petty EM. Characterisation and genetic mapping of a new X linked deafness syndrome. J Med Genet 2000; 37: 836–41.
  • Oosterwijk JC, Wischmeijer A, Losekoot M, Haraldson A, Theunissen G, van Gelderen I. A new X-linked mental retardation syndrome with distal limb defects, hearing impairment, verrucosis and immunodeficiency. Am J Hum Genet 1999; 65: A337.
  • Pai GS, Hane B, Joseph M, et al. A new X linked recessive syndrome of mental retardation and mild dysmorphism maps to Xq28. J Med Genet 1997; 34: 529–34.
  • Porteous MEM, Johnson H, Burn J, Curtis A, Lindsay S, Bhattacharya SS, Goodship JA. A new mental retardation syndrome mapping to the pericentrometric region of the X chromosome. Am J Hum Genet 1992; 51: A106.
  • Seemanova E, Lesny I. X-linked microcephaly, microphthalmia, microcornea, congenital cataract, hypogenitalism, mental deficiency, growth retardation, spasticity: possible new syndrome. Am J Med Genet 1996; 66: 179–83.
  • Shrimpton AE, Daly KM, Hoo JJ. Mapping of a gene (MRXS9) for X-linked mental retardation, microcephaly, and variably short stature to Xq12-q21.31. Am J Med Genet 1999; 84: 293–9.
  • Brooks SS, Wisniewski K, Brown WT. New X-linked mental retardation (XLMR) syndrome with distinct facial appearance and growth retardation. Am J Med Genet 1994; 51: 586–90.
  • Stevenson RE, Hane B, Arena JF, et al. Arch fingerprints, hypotonia, and areflexia associated with X linked mental retardation. J Med Genet 1997; 34: 465–9.
  • Stoll C, Geraudel A, Chauvin A. New X-linked syndrome of mental retardation, short stature, and hypertelorism. Am J Med Genet 1991; 39: 474–8.
  • Tariverdian G, Froster-Iskenius U, Deuschl G, Wolff G. Mental retardation, acromegalic face, and megalotestes in two half-brothers: a specific form of X-linked mental retardation without fra(X)(q)? Am J Med Genet 1991; 38: 208–11.
  • Turner G, Gedeon A, Mulley J. X-linked mental retardation with heterozygous expression and macrocephaly: pericentromeric gene localization. Am J Med Genet 1994; 51: 575–80.
  • Turner G, Gedeon A, Kerr B, et al. Syndromic form of X-linked mental retardation with marked hypotonia in early life, severe mental handicap, and difficult adult behavior maps to Xp22. Am J Med Genet 2003; 117A: 245–50.
  • Vasquez SB, Hurst DL, Sotos JF. X-linked hypogonadism, gynecomastia, mental retardation, short stature, and obesity—a new syndrome. J Pediatr 1979; 94: 56–60.
  • Vles JS, Fryns JP, Folmer K, et al. Corpus callosum agenesis, spastic quadriparesis and irregular lining of the lateral ventricles on CT-scan: a distinct X-linked mental retardation syndrome? Genet Couns 1990; 1: 97–102.
  • Young ID, Hughes HE. Sex-linked mental retardation, short stature, obesity, and hypogonadism: report of a family. J Ment Defic Res 1982; 26: 153–62.
  • Arena JF, Schwartz C, Stevenson R, et al. Spastic paraplegia with iron deposits in the basal ganglia: a new X-linked mental retardation syndrome. Am J Med Genet 1992; 43: 479–90.
  • des Portes V, Bachner L, Bruls T, et al. X-linked neurodegenerative syndrome with congenital ataxia, late-onset progressive myoclonic encephalopathy and selective macular degeneration, linked to Xp22.33-pter. Am J Med Genet 1996; 64: 69–72.
  • Claes S, Devriendt K, Van Goethem G, et al. Novel syndromic form of X-linked complicated spastic paraplegia. Am J Med Genet 2000; 94: 1–4.
  • Strain L, Wright AF, Bonthron DT. Fried syndrome is a distinct X linked mental retardation syndrome mapping to Xp22. J Med Genet 1997; 34: 535–40.
  • Garcia CC, Buddles MRH, Seager M, Goodship JA. A family with X-linked epilepsy mapping to Xp11-Xq13. Am J Hum Genet 1999; 65: A250.
  • Hamel BC, Wesseling P, Renier WO, et al. A new X linked neurodegenerative syndrome with mental retardation, blindness, convulsions, spasticity, mild hypomyelination, and early death maps to the pericentromeric region. J Med Genet 1999; 36: 140–43.
  • Tranebjaerg L, Lou H, Andresen J. New X-linked syndrome with apraxia, ataxia, and mental deficiency: clinical, cytogenetic and neuropsychological studies in two Danish families. Am J Med Genet 1992; 43: 498–504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.